The similar results has been reported and published in Nature. Roche (Herceptin, HER2-antibody) should be one of secret party, they are too big to name on SPL reports. Btw, the critical utmost achievement for DEP is HER2-DEP, cause now Herceptin is confirmed as supporting chemotherapy, it just blocked the growth signals of cells, and prevent cancer recurrent rather than kill cancel cells.
So HER2-DEP-toxic cell drugs should be developed to fill the gaps.
DEP-Trastuzumab, page-6
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
